Fast Healthcare Interoperability Resources (FHIR) represents a significant step in how we manage and exchange information and is rapidly gaining acceptance.
Join industry experts Mike Baird and Gary Saner as they provide an introduction to the FHIR initiative, explore some current applications as well as the impacts, benefits and prospective timelines.
Plus, you’ll explore the prospective timelines and next steps for FHIR implementations and what it means for the future of healthcare.
Learning objectives:
- Brief history and benefits of FHIR and the importance of interoperability in the healthcare sector
- Learn how various regulatory bodies are currently working and leveraging FHIR to improve processes with: EU EMA medicinal product information, US FDA Drug Labeling, Health Canada product monograph labeling
- Explore the prospective timelines and next steps for FHIR implementations and what it means for the future of healthcare
Presenters:
Mike is committed to continuously improving the existing software portfolio and at the same time also delivering new and innovative solutions to exceed customer needs. He has more than 25 years of experience working with global packaging, labeling, pre-media and artwork management leaders in the pharmaceutical and medical device sectors. Ensuring that the related risks of manual proofreading and approval processes are identified and solved quickly and easily, allowing only approved content to be printed or published.
Learn MoreGary is a subject matter expert on Drug Labeling, Medical Device UDI, and other structured content reporting to regulatory agencies and commercial organizations. He has over 40 years of experience in software development, process management, and data administration, with the last 19 years focused on the Life Sciences industry. With a deep understanding of regulations, business requirements, and systems, he has helped shape and implement successful solutions at Reed Tech for data management, validation, processing, and submission of Drug Labeling content, Cosmetic information, and Medical Device UDI data. He serves as chair of the industry’s Structured Product Labeling (SPL) Technical Team.
Learn Moree-PIL legislation: what it means for patient safety and sustainability
More regulators now accept electronic patient information leaflets, and many encourage them. The hard part is the transition. Your printed and online content has to match exactly, or patient safety is at risk.
In this 57-minute webcast, Peter Muller (Schlafender Hase) and Ashley Goldie (Aultra) walk you through the latest country regulations and guidance on e-PILs. You’ll see how the shift affects your current labeling and artwork processes. You’ll also get practical strategies for getting e-PIL content accurate and right the first time.